STEAP2 and prostate cancer: Androgen-dependent prostate cancer CWR22 xenograft tumours (grown in mice fed with testosterone pellets) displayed low STAMP1 expression compared to their relapsed derivatives (CWR22R tumours), suggesting STAMP1 was indicated in tumour progression and relapse.